Search research articles
Contact Us
Filters
Showing results (331-340 of 471) with videos related to
Page
of 48
Sort By:
Journal of Medical Imaging and Radiation Oncology
|
July 23, 2013
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy
Mateya E Trinkaus, Rob Blum, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer
Zoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Inorganic Chemistry
|
March 15, 2019
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups
Brett M Paterson, Carleen Cullinane, Peter J Crouch, et al.
Journal of Medical Imaging and Radiation Oncology
|
February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
Mateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
Bioconjugate Chemistry
|
March 31, 2021
Imaging Somatostatin Positive Tumors with Tyr<sup>3</sup>-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
Elske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models
Carleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 30, 2014
Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography
Brett M Paterson, Gojko Buncic, Lachlan E McInnes, et al.
Clinical and Translational Radiation Oncology
|
April 17, 2018
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
Sweet Ping Ng, Jennifer Tan, Glen Osbourne, et al.
Angewandte Chemie (International Ed. in English)
|
August 23, 2019
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention
Nicholas A Zia, Carleen Cullinane, Jessica K Van Zuylekom, et al.
Page
of 48
Search research articles
Search
Showing results (331-340 of 471) with videos related to
Sort By:
Page
of 48
Journal of Medical Imaging and Radiation Oncology
|
July 23, 2013
Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy
Mateya E Trinkaus, Rob Blum, Danny Rischin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2012
Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer
Zoe Wainer, Marissa G Daniels, Jason Callahan, et al.
Inorganic Chemistry
|
March 15, 2019
Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups
Brett M Paterson, Carleen Cullinane, Peter J Crouch, et al.
Journal of Medical Imaging and Radiation Oncology
|
February 18, 2014
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
Mateya E Trinkaus, Rodney J Hicks, Richard J Young, et al.
Bioconjugate Chemistry
|
March 31, 2021
Imaging Somatostatin Positive Tumors with Tyr<sup>3</sup>-Octreotate/Octreotide Conjugated to Desferrioxamine B Squaramide Radiolabeled with either Zirconium-89 or Gallium-68
Asif Noor, Jessica K Van Zuylekom, Stacey E Rudd, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 30, 2015
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
Elske Quak, Pierre-Yves Le Roux, Michael S Hofman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 19, 2011
Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models
Carleen Cullinane, Donna S Dorow, Susan Jackson, et al.
Dalton Transactions (Cambridge, England : 2003)
|
October 30, 2014
Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography
Brett M Paterson, Gojko Buncic, Lachlan E McInnes, et al.
Clinical and Translational Radiation Oncology
|
April 17, 2018
Follow up results of a prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer
Sweet Ping Ng, Jennifer Tan, Glen Osbourne, et al.
Angewandte Chemie (International Ed. in English)
|
August 23, 2019
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention
Nicholas A Zia, Carleen Cullinane, Jessica K Van Zuylekom, et al.
Page
of 48